FdaApplication

BLA 761390

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGalderma Laboratories, L.P.
application_typeBLA
approval_date2024-08-12

Products (1)

ProductActive ingredientStrengthDosage form
NEMLUVIONEMOLIZUMAB-ILTO30MGFor Injection

1 product